| Mr Sharad Kothari, MD | |
|
3979 Laconia Ave, Bronx, NY 10466-4916 | |
| (347) 442-7656 | |
| (347) 442-7049 |
| Full Name | Mr Sharad Kothari |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 3979 Laconia Ave, Bronx, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245462621 | NPI | - | NPPES |
| 1310097 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 296265 (New York) | Primary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 253041 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hudson Valley Hospice | Poughkeepsie, NY | Hospice |
| Beth Abraham Center For Rehabilitation And Nursing | Bronx, NY | Nursing home |
| Regeis Care Center | Bronx, NY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mehta Medical Pc | 5092059196 | 2 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
In a groundbreaking new partnership, national bathhouse chain FLEX Spas has teamed up with AIDS Healthcare Foundation, the largest AIDS organization in the United States, to help bolster its safety standards and protect the public health of its patrons.
› Verified 6 days ago
| Entity Name | Palekar Family Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518954437 PECOS PAC ID: 1759273139 Enrollment ID: O20040329001416 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
In a groundbreaking new partnership, national bathhouse chain FLEX Spas has teamed up with AIDS Healthcare Foundation, the largest AIDS organization in the United States, to help bolster its safety standards and protect the public health of its patrons.
› Verified 6 days ago
| Entity Name | Mehta Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861977316 PECOS PAC ID: 5092059196 Enrollment ID: O20181130000066 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
In a groundbreaking new partnership, national bathhouse chain FLEX Spas has teamed up with AIDS Healthcare Foundation, the largest AIDS organization in the United States, to help bolster its safety standards and protect the public health of its patrons.
› Verified 6 days ago
| Entity Name | Visiting Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083241392 PECOS PAC ID: 2961824842 Enrollment ID: O20200623001067 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
In a groundbreaking new partnership, national bathhouse chain FLEX Spas has teamed up with AIDS Healthcare Foundation, the largest AIDS organization in the United States, to help bolster its safety standards and protect the public health of its patrons.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Sharad Kothari, MD 3979 Laconia Ave, Bronx, NY 10466-4916 Ph: (347) 442-7656 | Mr Sharad Kothari, MD 3979 Laconia Ave, Bronx, NY 10466-4916 Ph: (347) 442-7656 |
News Archive
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
In a groundbreaking new partnership, national bathhouse chain FLEX Spas has teamed up with AIDS Healthcare Foundation, the largest AIDS organization in the United States, to help bolster its safety standards and protect the public health of its patrons.
› Verified 6 days ago
Selina Sultana Zaman, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |